(Q42927171)

11 November 2017

title

Neuropsychiatric adverse events with ritonavir-boosted darunavir monotherapy in HIV-infected individuals: a randomised prospective study (English)

1 reference

11 November 2017

1 reference

1 reference

3

1 reference

11 November 2017

2

Gerd Fätkenheuer

1 reference

11 November 2017

Yvon van Delft

5

0 references

author name string

Alan Winston

series ordinal

1

1 reference

11 November 2017

Andrew Hill

series ordinal

4

1 reference

11 November 2017

Christiane Moecklinghoff

series ordinal

6

1 reference

11 November 2017

publication date

1 May 2010

1 reference

11 November 2017

1 reference

11 November 2017

volume

11

1 reference

11 November 2017

issue

3

1 reference

11 November 2017

page(s)

163-169

1 reference

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Correlations between computerized battery testing and a memory questionnaire for identification of neurocognitive impairment in HIV type 1-infected subjects on stable antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Variable patterns of neuropsychological performance in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Neurocognition in individuals co-infected with HIV and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Lopinavir/ritonavir monotherapy as maintenance treatment in HIV-infected individuals with virological suppression: results from a pilot study in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Low atazanavir concentrations in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

Improved cognitive function as a consequence of hepatitis C virus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1103-163

21 January 2018

Identifiers

DOI

10.1310/HCT1103-163

1 reference

11 November 2017

1 reference